A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Enzo Biochem Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,435,129 shares of ENZ stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,435,129
Previous 2,479,195 1.78%
Holding current value
$2.65 Million
Previous $3.45 Million 10.24%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.21 - $1.5 $53,319 - $66,099
-44,066 Reduced 1.78%
2,435,129 $3.09 Million
Q4 2023

Feb 13, 2024

SELL
$1.21 - $1.44 $93,011 - $110,691
-76,869 Reduced 3.01%
2,479,195 $3.45 Million
Q3 2023

Nov 14, 2023

SELL
$1.3 - $1.87 $193,440 - $278,256
-148,800 Reduced 5.5%
2,556,064 $3.58 Million
Q2 2023

Aug 11, 2023

SELL
$1.84 - $2.66 $119,968 - $173,432
-65,200 Reduced 2.35%
2,704,864 $4.98 Million
Q1 2023

May 12, 2023

SELL
$1.0 - $2.51 $43,900 - $110,188
-43,900 Reduced 1.56%
2,770,064 $6.73 Million
Q4 2022

Feb 13, 2023

SELL
$1.16 - $2.42 $111,011 - $231,594
-95,700 Reduced 3.29%
2,813,964 $4.02 Million
Q3 2022

Nov 14, 2022

SELL
$2.14 - $2.73 $227,910 - $290,745
-106,500 Reduced 3.53%
2,909,664 $6.49 Million
Q2 2022

Aug 12, 2022

BUY
$2.0 - $3.0 $10,000 - $15,000
5,000 Added 0.17%
3,016,164 $6.24 Million
Q1 2022

May 13, 2022

SELL
$2.9 - $3.47 $242,440 - $290,092
-83,600 Reduced 2.7%
3,011,164 $8.73 Million
Q4 2021

Feb 11, 2022

SELL
$3.17 - $4.09 $365,501 - $471,577
-115,300 Reduced 3.59%
3,094,764 $9.93 Million
Q3 2021

Nov 12, 2021

SELL
$3.01 - $3.77 $148,092 - $185,484
-49,200 Reduced 1.51%
3,210,064 $11.4 Million
Q2 2021

Aug 13, 2021

SELL
$2.86 - $3.61 $233,376 - $294,576
-81,600 Reduced 2.44%
3,259,264 $10.3 Million
Q1 2021

May 13, 2021

SELL
$2.61 - $4.08 $562,086 - $878,664
-215,359 Reduced 6.06%
3,340,864 $11.5 Million
Q4 2020

Feb 10, 2021

SELL
$1.82 - $2.61 $55,510 - $79,605
-30,500 Reduced 0.85%
3,556,223 $8.96 Million
Q3 2020

Nov 13, 2020

BUY
$2.02 - $3.02 $245,318 - $366,763
121,445 Added 3.5%
3,586,723 $7.57 Million
Q2 2020

Aug 13, 2020

BUY
$2.12 - $3.22 $324,996 - $493,626
153,300 Added 4.63%
3,465,278 $7.76 Million
Q1 2020

May 14, 2020

SELL
$1.82 - $3.87 $76,130 - $161,882
-41,830 Reduced 1.25%
3,311,978 $8.38 Million
Q4 2019

Feb 13, 2020

BUY
$2.57 - $3.68 $139,409 - $199,621
54,245 Added 1.64%
3,353,808 $8.82 Million
Q3 2019

Nov 13, 2019

BUY
$3.01 - $4.0 $146,075 - $194,120
48,530 Added 1.49%
3,299,563 $11.9 Million
Q2 2019

Aug 12, 2019

BUY
$2.79 - $4.31 $183,593 - $283,615
65,804 Added 2.07%
3,251,033 $11 Million
Q1 2019

May 14, 2019

BUY
$2.54 - $4.02 $247,799 - $392,187
97,559 Added 3.16%
3,185,229 $8.7 Million
Q4 2018

Feb 13, 2019

BUY
$2.46 - $4.2 $7.6 Million - $13 Million
3,087,670 New
3,087,670 $8.58 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $53.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.